ABRYSVO is a vaccine indicated for the prevention of LRTD caused by RSV in adults aged 60 years and older.4
Explore the efficacy and safety profile of ABRYSVO
See Pfizer's convenient, needle-free‡ reconstitution kit
‡Needle required for intramuscular injection is not included.
Learn more about costs and coverage, and get the support you need
CDC=Centers for Disease Control and Prevention; LRTD=lower respiratory tract disease; MMWR=Morbidity and Mortality Weekly Report; RSV=respiratory syncytial virus.
Explore a range of resources related to ABRYSVO, including videos, information about upcoming events, and more.
Explore a range of resources related to ABRYSVO, including videos, information about upcoming events, and more.